Offer - Urjas Oil for just ₹ 1 X
Carvistar 6.25 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of High BP. Carvistar 6.25 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Carvistar 6.25 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Carvistar 6.25 Tablet can also lead to other problems, which have been listed below. Such side effects of Carvistar 6.25 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Carvistar 6.25 Tablet's effect is Moderate during pregnancy and Safe for lactating mothers. It is important to know if Carvistar 6.25 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Carvistar 6.25 Tablet related warnings section.
Individuals suffering from medical conditions like Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) must refrain from the use of Carvistar 6.25 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Carvistar 6.25 Tablet contraindications section.
Additionally, Carvistar 6.25 Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Carvistar 6.25 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Carvistar 6.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Carvistar 6.25 Tablet safe for pregnant women?
Carvistar can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Carvistar right away. Take your doctor's advice before taking it again.
Is the use of Carvistar 6.25 Tablet safe during breastfeeding?
Carvistar is completely safe for breastfeeding women.
What is the effect of Carvistar 6.25 Tablet on the Kidneys?
Carvistar is completely safe for kidneys.
What is the effect of Carvistar 6.25 Tablet on the Liver?
Carvistar may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Carvistar 6.25 Tablet on the Heart?
Side effects of Carvistar rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Carvistar 6.25 Tablet unless your doctor advises you to do so -
Is this Carvistar 6.25 Tablet habit forming or addictive?
Carvistar 6.25 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Carvistar 6.25 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume Carvistar 6.25 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Carvistar 6.25 Tablet in mental disorders is not effective.
Interaction between Food and Carvistar 6.25 Tablet
Carvistar 6.25 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Carvistar 6.25 Tablet
Consumption of alcohol and Carvistar 6.25 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)